Acrivon Therapeutics Common Stock Price on December 31, 2023
| ACRV Stock | 9.59 1.13 13.36% |
If you're considering investing in Acrivon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acrivon Therapeutics stands at 9.59, as last reported on the 5th of May, with the highest price reaching 10.29 and the lowest price hitting 8.31 during the day. Acrivon Therapeutics is risky given 3 months investment horizon. Acrivon Therapeutics secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.03% are justified by taking the suggested risk. Use Acrivon Therapeutics Mean Deviation of 7.06, downside deviation of 6.63, and Risk Adjusted Performance of 0.1227 to evaluate company specific risk that cannot be diversified away.
At this time, Acrivon Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 249.6 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 117.8 M in 2024. . Price Earnings Ratio is likely to drop to -1.89 in 2024. Price Book Value Ratio is likely to drop to 0.47 in 2024. Acrivon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acrivon |
Sharpe Ratio = 0.1813
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ACRV | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.2 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.03 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Acrivon Therapeutics is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acrivon Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.5447 | Book Value 5.381 | Enterprise Value 94.3 M | Enterprise Value Ebitda (2.79) | Shares Float 8.9 M |
Acrivon Therapeutics Valuation on December 31, 2023
It is possible to determine the worth of Acrivon Therapeutics on a given historical date. On December 31, 2023 Acrivon was worth 4.98 at the beginning of the trading date compared to the closed value of 4.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acrivon Therapeutics stock. Still, in general, we apply an absolute valuation method to find Acrivon Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acrivon Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acrivon Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 5.00 | 5.05 | 4.93 | 4.98 | 14,951 | |
12/29/2023 | 4.98 | 5.05 | 4.89 | 4.92 | 22,067 |
| 4.89 | 5.25 | 4.81 | 5.01 | 111,128 |
| Backtest Acrivon Therapeutics | | | Acrivon Therapeutics History | | | Acrivon Therapeutics Valuation | Previous | Next |
Acrivon Therapeutics Trading Date Momentum on December 31, 2023
| On January 02 2024 Acrivon Therapeutics Common was traded for 5.01 at the closing time. The top price for the day was 5.25 and the lowest listed price was 4.81 . The trading volume for the day was 111.1 K. The trading history from January 2, 2024 was a factor to the next trading day price increase. The overall trading delta against the next closing price was 1.83% . The overall trading delta against the current closing price is 7.52% . |
Acrivon Therapeutics Fundamentals Correlations and Trends
By evaluating Acrivon Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acrivon Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acrivon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acrivon Therapeutics Stock history
Acrivon Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acrivon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acrivon Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acrivon Therapeutics stock prices may prove useful in developing a viable investing in Acrivon Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 22.1 M | 23.6 M | |
| Net Loss | -28.1 M | -29.5 M |
Acrivon Therapeutics Quarterly Net Working Capital |
|
Acrivon Therapeutics Stock Technical Analysis
Acrivon Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Acrivon Therapeutics Period Price Range
Low | December 29, 2023
| High |
4.98 | 4.92 |
Acrivon Therapeutics May 5, 2024 Market Strength
Market strength indicators help investors to evaluate how Acrivon Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acrivon Therapeutics shares will generate the highest return on investment. By undertsting and applying Acrivon Therapeutics stock market strength indicators, traders can identify Acrivon Therapeutics Common entry and exit signals to maximize returns
Acrivon Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acrivon Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acrivon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acrivon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1227 | |||
| Jensen Alpha | 1.8 | |||
| Total Risk Alpha | 0.7585 | |||
| Sortino Ratio | 0.2875 | |||
| Treynor Ratio | 0.7851 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acrivon Therapeutics Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Acrivon Stock analysis
When running Acrivon Therapeutics' price analysis, check to measure Acrivon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics is operating at the current time. Most of Acrivon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics' price. Additionally, you may evaluate how the addition of Acrivon Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Acrivon Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acrivon Therapeutics. If investors know Acrivon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acrivon Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.74) | Return On Assets (0.26) | Return On Equity (0.41) |
The market value of Acrivon Therapeutics is measured differently than its book value, which is the value of Acrivon that is recorded on the company's balance sheet. Investors also form their own opinion of Acrivon Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Acrivon Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acrivon Therapeutics' market value can be influenced by many factors that don't directly affect Acrivon Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acrivon Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acrivon Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acrivon Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.